Haleon (HLN) Cost of Revenue (2021 - 2023)

Haleon (HLN) posted Cost of Revenue of $4.1 billion for Q4 2023, up 211.26% on a QoQ basis from $1.3 billion in Q2 2023, and up 13.45% year-over-year from $3.6 billion in Q4 2022.

Haleon (HLN) Cost of Revenue (2021 - 2023) Analysis & Trends

Haleon's Cost of Revenue history runs 3 years deep, the most recent figure standing at $4.1 billion for Q4 2023.

  • Quarterly Cost of Revenue rose 13.45% year-over-year to $4.1 billion in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $10.3 billion (changed N/A YoY) and the FY2025 annual result came in at $5.2 billion, down 7.59% from the prior year.
  • Cost of Revenue was $4.1 billion for Q4 2023 at Haleon, up from $1.3 billion in the prior quarter.
  • Across five years, Cost of Revenue topped out at $4.1 billion in Q4 2023 and bottomed at $1.3 billion in Q2 2023.
  • A 3-year average of $2.7 billion and a median of $3.0 billion in 2022 frame the typical range for Cost of Revenue.
  • Annual changes were most pronounced in 2022 — Cost of Revenue declined 1.49% — and 2023, when it grew 13.45%.
  • Haleon's Cost of Revenue stood at $3.6 billion in 2021, then slipped by 1.49% to $3.6 billion in 2022, then increased by 13.45% to $4.1 billion in 2023.
  • Business Quant data shows HLN's Cost of Revenue at $4.1 billion in Q4 2023, $1.3 billion in Q2 2023, and $1.4 billion in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 2.01 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 641.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 2.59 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 133.40 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 2.36 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 13.80 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 586.00 Mn
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn 46.90 Mn

Historic Data

Download Data
DateValue
Dec 31, 2023 4.06 Bn
Dec 31, 2023 4.06 Bn
Jun 30, 2023 1.30 Bn
Jun 30, 2023 1.30 Bn
May 3, 2023 1.40 Bn
May 3, 2023 1.40 Bn
Dec 31, 2022 3.58 Bn
Dec 31, 2022 3.58 Bn
Sep 20, 2022 2.43 Bn
Sep 20, 2022 2.43 Bn
Dec 31, 2021 3.63 Bn
Dec 31, 2021 3.63 Bn